GTS Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
33,053
+10,504
+47% +$585K 0.06% 230
2025
Q4
$1.26M Sell
22,549
-5,221
-19% -$271K 0.04% 350
2025
Q3
$1.33M Buy
27,770
+8,822
+47% +$395K 0.05% 311
2025
Q2
$769K Buy
18,948
+641
+4% +$25.8K 0.03% 467
2025
Q1
$802K Buy
+18,307
New +$808K 0.03% 474
2024
Q4
Sell
-25,284
Closed -$1.12M 4485
2024
Q3
$1.12M Buy
25,284
+18,308
+262% +$784K 0.02% 2056
2024
Q2
$278K Sell
6,976
-24,898
-78% -$1.01M 0.01% 3191
2024
Q1
$1.37M Buy
31,874
+19,712
+162% +$849K 0.04% 1741
2023
Q4
$506K Buy
+12,162
New +$461K 0.01% 2786

Other funds holding XPH